Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Harshita Dalvi
Observed name:
Dalvi, Harshita
Institution:
National Institute of Pharmaceutical Education and Research
Observed institution:
National Institute of Pharmaceutical Education and Research
ORCID:
0000-0003-4845-926X
Observed ORCID:
0000-0003-4845-926X
OpenAlex ID:
A5048567399
Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis
2022
·
Harsha Jain
, Devabattula Geetanjali
, et al.
·
Journal of Drug Delivery Science and Technology
·
47
Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment
2021
·
Harsha Jain
, Aditi Rajan Bhat
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
31
Armamentarium of Cryoprotectants in Peptide Vaccines: Mechanistic Insight, Challenges, Opportunities and Future Prospects
2021
·
Harshita Dalvi
, Aditi Bhat
, et al.
·
International Journal of Peptide Research and Therapeutics
·
21
PDF
Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal
2020
·
Aditi Bhat
, Harshita Dalvi
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
21
PDF
Topical delivery of Bruton’s tyrosine kinase inhibitor and curcumin-loaded nanostructured lipid carrier gel: Repurposing strategy for the psoriasis management
2022
·
Harsha Jain
, Geetanjali Devabattula
, et al.
·
Pharmaceutical Development and Technology
·
11
Nanomaterials in nose-to-brain delivery
2022
·
Harsha Jain
, Harshita Dalvi
, et al.
·
Elsevier eBooks
·
1
Roles of online social media platforms and artificial intelligence in diffusing the impact of COVID-19 as scientists find a cure
2022
·
Harshita Dalvi
, Aditi Bhat
, et al.
·
Elsevier eBooks
PDF
Show more works
View as search
Works count:
10
Citation count:
132
H-index:
5
I10-index:
5
Year
Topic
Type